Warfarin and Non-Steroidal Anti-Inflammatory Drugs (NSAID) Customized Alert

University of Pennsylvania

Status: Completed

Conditions: Warfarin and NSAID

Treatments: Behavioral: Electronic Alert

Study type: Interventional

Funder types: Other

Identifiers

NCT00880932

803787

Details and patient eligibility

About

The hypothesis is that a newly formatted electronic alert that requires the prescriber to pause and enter a specific "reason for override" on this alert, will cause prescribers in the intervention group to be significantly less likely to prescribe the combination of warfarin and NSAID than prescribers in the control group.

Enrollment: 1,865 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• All resident physicians (RP) and nurse practitioners (NP) involved in inpatient care at two hospitals of the University of Pennsylvania

Exclusion criteria

• None

Trial design

1,865 participants in 2 patient groups

customized electronic alert

Experimental group

Description:

This intervention was not targeted to patients with a disease but to the providers. The intervention was not a drug but a customized electronic alert, requesting the prescriber to specify a "reason for override" whenever the combination drugs of warfarin and NSAID were ordered together.

Treatment:

Behavioral: Electronic Alert

Standard practice

No Intervention group

Description:

The control group was not patients but the providers. Providers in the control group continued with the standard practice of receiving passive alerts in the form of message boxes warning the provider not to prescribe the combination drugs warfarin and NSAID.